|  | Conditions & Treatments | Migraine

Understanding CGRP Migraine Treatments: Benefits, Options, and What to Expect

What Is CGRP?

Calcitonin gene‑related peptide (CGRP) is a protein released by nerve cells during migraine attacks. It widens blood vessels, heightens inflammation, and amplifies headache pain, making attacks last longer.

How CGRP‑Targeted Medications Work

These drugs—often called anti‑CGRPs, CGRP inhibitors, or CGRP antagonists—prevent CGRP from binding to its receptors or neutralize the peptide itself. By blocking CGRP’s action, the medications can both prevent migraine attacks and lessen their severity.

  • They block receptor sites in and around the brain where CGRP binds.
  • They bind directly to CGRP, rendering it inactive.

Who May Benefit

Doctors may prescribe CGRP therapies for:

  • Chronic migraine
  • Episodic migraine
  • Migraine with or without aura

They are especially useful for patients who have not responded adequately to traditional migraine treatments.

Effectiveness

Clinical studies show promising results. In a 2018 trial, nearly one‑third of participants with episodic migraine experienced a 50% reduction in migraine days after receiving a CGRP medication. A 2022 study found that CGRP therapies remain effective for years, even in patients who overuse other migraine drugs.

Administration Options

Most CGRP treatments are administered via injection, but oral and nasal options also exist.

Injectable/Infusion Options (monthly or quarterly)

  • Erenumab (Aimovig) – monthly
  • Fremanezumab (Ajovy) – monthly or quarterly
  • Galcanezumab (Emgality) – monthly
  • Eptinezumab (Vyepti) – intravenous infusion every 3 months

Oral Options

  • Rimegepant (Nurtec ODT)
  • Atogepant (Qulipta)

Nasal Spray

Zavegepant (Zavzpret) – daily nasal spray.

Injection schedules typically range from once a month to once every three months, and many patients can self‑administer at home after proper training.

Potential Side Effects

Common adverse events include mild nausea, dry mouth, abdominal discomfort, and sleepiness. Injection‑site reactions such as pain, redness, or infection can occur; proper hand hygiene and rotating injection sites help minimize risk.

Because CGRP helps dilate blood vessels, long‑term blockade may affect blood pressure and heart function. More research is needed to determine safety in patients with recent cardiovascular events (e.g., stroke or heart attack) or chronic conditions like diabetes.

Insurance and Access

Many insurance plans require patients to have tried and failed at least one other migraine preventive before covering CGRP therapy. Check your plan’s criteria and consider patient‑assistance programs—such as Pfizer’s support for rimegepant—if coverage is denied.

Getting Started

If you think CGRP treatment may be right for you, discuss it with your physician. They can evaluate your migraine history, comorbid conditions, and insurance requirements.

Keeping a daily headache diary before and during treatment helps your doctor gauge effectiveness and monitor side effects.

Migraine - Related Articles